300 related articles for article (PubMed ID: 1531086)
1. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
Bours V; Burd PR; Brown K; Villalobos J; Park S; Ryseck RP; Bravo R; Kelly K; Siebenlist U
Mol Cell Biol; 1992 Feb; 12(2):685-95. PubMed ID: 1531086
[TBL] [Abstract][Full Text] [Related]
2. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
3. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
[TBL] [Abstract][Full Text] [Related]
4. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
[TBL] [Abstract][Full Text] [Related]
5. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
6. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
7. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
Ryseck RP; Bull P; Takamiya M; Bours V; Siebenlist U; Dobrzanski P; Bravo R
Mol Cell Biol; 1992 Feb; 12(2):674-84. PubMed ID: 1732739
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
Mercurio F; Didonato J; Rosette C; Karin M
DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
[TBL] [Abstract][Full Text] [Related]
9. p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Capobianco AJ; Chang D; Mosialos G; Gilmore TD
J Virol; 1992 Jun; 66(6):3758-67. PubMed ID: 1533881
[TBL] [Abstract][Full Text] [Related]
10. Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif.
Dobrzanski P; Ryseck RP; Bravo R
Mol Cell Biol; 1993 Mar; 13(3):1572-82. PubMed ID: 8441398
[TBL] [Abstract][Full Text] [Related]
11. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
12. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
Liou HC; Nolan GP; Ghosh S; Fujita T; Baltimore D
EMBO J; 1992 Aug; 11(8):3003-9. PubMed ID: 1639070
[TBL] [Abstract][Full Text] [Related]
13. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
Nolan GP; Ghosh S; Liou HC; Tempst P; Baltimore D
Cell; 1991 Mar; 64(5):961-9. PubMed ID: 2001591
[TBL] [Abstract][Full Text] [Related]
14. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
Diehl JA; Hannink M
J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
16. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
[TBL] [Abstract][Full Text] [Related]
17. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
Davis N; Ghosh S; Simmons DL; Tempst P; Liou HC; Baltimore D; Bose HR
Science; 1991 Sep; 253(5025):1268-71. PubMed ID: 1891714
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation.
Arima N; Molitor JA; Smith MR; Kim JH; Daitoku Y; Greene WC
J Virol; 1991 Dec; 65(12):6892-9. PubMed ID: 1719236
[TBL] [Abstract][Full Text] [Related]
19. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
Ballard DW; Dixon EP; Peffer NJ; Bogerd H; Doerre S; Stein B; Greene WC
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1875-9. PubMed ID: 1542686
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Sif S; Gilmore TD
J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
